Secondary analysis of a placebo-controlled trial of extended-release naltrexone plus buprenorphine for cocaine dependence (n=301): THC-positive urine screens were associated with higher odds of cocaine-positive screens (OR 1.47, 95% CI 1.21–1.79).
Secondary analysisn = 301
Smith et al. Relationships between cannabis and cocaine use in a randomized trial of combined buprenorphine and naltrexone for DSM-IV cocaine dependence